SearcharxivSearch

arXiv subjects

Xiaomin Fang

Publications and source records attributed to Xiaomin Fang.

At least 19 recordsLinked to original sources

Reshaping Biomolecular Structure Prediction through Strategic Conformational Exploration with HelixFold-S1

Generating large ensembles of candidate conformations is standard for improving biomolecular structure prediction. Yet aimless sampling is inefficient and costly, producing many redundant conformations with limited diversity, particularly for complex multimeric assemblies. Here, we present HelixFold-S1, a guided planning approach specifically designed to enhance the structural prediction of biomolecular complexes by strategically targeting the most informative regions of conformational space to produce accurate conformations. For each complex, predicted inter-chain contact probabilities serve as a blueprint of the conformational space, guiding computational effort toward higher-probability, low-redundancy contacts that constrain structure generation. Across diverse biomolecular complex benchmarks, HelixFold-S1 achieves markedly higher structural accuracy than traditional unguided methods while reducing sampling requirements by an order of magnitude. Predicted contact probabilities also provide a rough indicator of prediction difficulty and sampling utility. These results demonstrate that guided planning reshapes conformational exploration and enables more efficient and accurate structural inference.

q-bio.BM

End-to-End Reverse Screening Identifies Protein Targets of Small Molecules Using HelixFold3

Identifying protein targets for small molecules, or reverse screening, is essential for understanding drug action, guiding compound repurposing, predicting off-target effects, and elucidating the molecular mechanisms of bioactive compounds. Despite its critical role, reverse screening remains challenging because accurately capturing interactions between a small molecule and structurally diverse proteins is inherently complex, and conventional step-wise workflows often propagate errors across decoupled steps such as target structure modeling, pocket identification, docking, and scoring. Here, we present an end-to-end reverse screening strategy leveraging HelixFold3, a high-accuracy biomolecular structure prediction model akin to AlphaFold3, which simultaneously models the folding of proteins from a protein library and the docking of small-molecule ligands within a unified framework. We validate this approach on a diverse and representative set of approximately one hundred small molecules. Compared with conventional reverse docking, our method improves screening accuracy and demonstrates enhanced structural fidelity, binding-site precision, and target prioritization. By systematically linking small molecules to their protein targets, this framework establishes a scalable and straightforward platform for dissecting molecular mechanisms, exploring off-target interactions, and supporting rational drug discovery.

q-bio.BM

HelixVS: Deep Learning-Enhanced Structure-Based Platform for Screening and Design

Drug discovery through virtual screening (VS) has become a popular strategy for identifying hits against protein targets. Alongside VS, molecular design further expands accessible chemical space. Together, these approaches have the potential to reduce the cost and time needed for manual selection and wet-laboratory experiments, thereby accelerating drug discovery pipelines. Improving the cost-effectiveness of virtual screening is a significant challenge, aiming to explore larger compound libraries while maintaining lower screening costs. Here, we present HelixVS, a structure-based VS platform enhanced by deep learning models. HelixVS integrates a precise deep learning-based pose-scoring model and a pose-screening module into a multi-stage VS process, enabling more effective screening of active compounds. Compared to classic molecular docking tools like Vina, HelixVS demonstrated significantly improved screening performance across nearly a hundred targets, achieving an average 2.6-fold higher enrichment factor (EF) and more than 10 times faster screening speed. We applied HelixVS in four drug development pipelines, targeting both traditional competitive drug-binding pockets and novel protein-protein interaction interfaces. Wet-lab validations across these pipelines consistently identified active compounds, with over 10% of the molecules tested in wet labs demonstrating activity at uM or even nM levels. This demonstrates the ability of HelixVS to identify high-affinity ligands for various targets and pockets.In addition, the HelixVS platform has been extended with HelixVS-Syn, which enables design of novel compounds from reference scaffolds. These designed molecules are seamlessly integrated into the HelixVS screening workflow, allowing researchers to explore both existing chemical libraries and novel chemical space with high affinity, synthetic accessibility, and structural novelty.

q-bio.BM

BioScore: A Foundational Scoring Function For Diverse Biomolecular Complexes

Structural assessment of biomolecular complexes is vital for translating molecular models into functional insights, shaping our understanding of biology and aiding drug discovery. However, current structure-based scoring functions often lack generalizability across diverse biomolecular systems. We present BioScore, a foundational scoring function that addresses key challenges -- data sparsity, cross-system representation, and task compatibility -- through a dual-scale geometric graph learning framework with tailored modules for structure assessment and affinity prediction. BioScore supports a wide range of tasks, including affinity prediction, conformation ranking, and structure-based virtual screening. Evaluated on 16 benchmarks spanning proteins, nucleic acids, small molecules, and carbohydrates, BioScore consistently outperforms or matches 70 traditional and deep learning methods. Our newly proposed PPI Benchmark further enables comprehensive evaluation of protein-protein complex scoring. BioScore demonstrates broad applicability: (1) pretraining on mixed-structure data boosts protein-protein affinity prediction by up to 40% and antigen-antibody binding correlation by over 90%; (2) cross-system generalizability enables zero- and few-shot prediction with up to 71% correlation gain; and (3) its unified representation captures chemically challenging systems such as cyclic peptides, improving affinity prediction by over 60%. BioScore establishes a robust and generalizable framework for structural assessment across complex biomolecular landscapes.

physics.chem-ph

HelixDesign-Antibody: A Scalable Production-Grade Platform for Antibody Design Built on HelixFold3

Antibody engineering is essential for developing therapeutics and advancing biomedical research. Traditional discovery methods often rely on time-consuming and resource-intensive experimental screening. To enhance and streamline this process, we introduce a production-grade, high-throughput platform built on HelixFold3, HelixDesign-Antibody, which utilizes the high-accuracy structure prediction model, HelixFold3. The platform facilitates the large-scale generation of antibody candidate sequences and evaluates their interaction with antigens. Integrated high-performance computing (HPC) support enables high-throughput screening, addressing challenges such as fragmented toolchains and high computational demands. Validation on multiple antigens showcases the platform's ability to generate diverse and high-quality antibodies, confirming a scaling law where exploring larger sequence spaces increases the likelihood of identifying optimal binders. This platform provides a seamless, accessible solution for large-scale antibody design and is available via the antibody design page of PaddleHelix platform.

q-bio.BM

HelixDesign-Binder: A Scalable Production-Grade Platform for Binder Design Built on HelixFold3

Protein binder design is central to therapeutics, diagnostics, and synthetic biology, yet practical deployment remains challenging due to fragmented workflows, high computational costs, and complex tool integration. We present HelixDesign-Binder, a production-grade, high-throughput platform built on HelixFold3 that automates the full binder design pipeline, from backbone generation and sequence design to structural evaluation and multi-dimensional scoring. By unifying these stages into a scalable and user-friendly system, HelixDesign-Binder enables efficient exploration of binder candidates with favorable structural, energetic, and physicochemical properties. The platform leverages Baidu Cloud's high-performance infrastructure to support large-scale design and incorporates advanced scoring metrics, including ipTM, predicted binding free energy, and interface hydrophobicity. Benchmarking across six protein targets demonstrates that HelixDesign-Binder reliably produces diverse and high-quality binders, some of which match or exceed validated designs in predicted binding affinity. HelixDesign-Binder is accessible via an interactive web interface in PaddleHelix platform, supporting both academic research and industrial applications in antibody and protein binder development.

q-bio.BM

Technical Report of HelixFold3 for Biomolecular Structure Prediction

The AlphaFold series has transformed protein structure prediction with remarkable accuracy, often matching experimental methods. AlphaFold2, AlphaFold-Multimer, and the latest AlphaFold3 represent significant strides in predicting single protein chains, protein complexes, and biomolecular structures. While AlphaFold2 and AlphaFold-Multimer are open-sourced, facilitating rapid and reliable predictions, AlphaFold3 remains partially accessible through a limited online server and has not been open-sourced, restricting further development. To address these challenges, the PaddleHelix team is developing HelixFold3, aiming to replicate AlphaFold3's capabilities. Leveraging insights from previous models and extensive datasets, HelixFold3 achieves accuracy comparable to AlphaFold3 in predicting the structures of the conventional ligands, nucleic acids, and proteins. The initial release of HelixFold3 is available as open source on GitHub for academic research, promising to advance biomolecular research and accelerate discoveries. The latest version will be continuously updated on the HelixFold3 web server, providing both interactive visualization and API access.

q-bio.BM

Precise Antigen-Antibody Structure Predictions Enhance Antibody Development with HelixFold-Multimer

The accurate prediction of antigen-antibody structures is essential for advancing immunology and therapeutic development, as it helps elucidate molecular interactions that underlie immune responses. Despite recent progress with deep learning models like AlphaFold and RoseTTAFold, accurately modeling antigen-antibody complexes remains a challenge due to their unique evolutionary characteristics. HelixFold-Multimer, a specialized model developed for this purpose, builds on the framework of AlphaFold-Multimer and demonstrates improved precision for antigen-antibody structures. HelixFold-Multimer not only surpasses other models in accuracy but also provides essential insights into antibody development, enabling more precise identification of binding sites, improved interaction prediction, and enhanced design of therapeutic antibodies. These advances underscore HelixFold-Multimer's potential in supporting antibody research and therapeutic innovation.

q-bio.BM

Joint Design of 5' Untranslated Region and Coding Sequence of mRNA

Messenger RNA (mRNA) vaccines and therapeutics are emerging as powerful tools against a variety of diseases, including infectious diseases and cancer. The design of mRNA molecules, particularly the untranslated region (UTR) and coding sequence (CDS) is crucial for optimizing translation efficiency and stability. Current design approaches generally focus solely on either the 5' UTR or the CDS, which limits their ability to comprehensively enhance translation efficiency and stability. To address this, we introduce LinearDesign2, an algorithm that enables the co-design of the 5' UTR and CDS. This integrated approach optimizes translation initiation efficiency (TIE), codon adaptation index (CAI), and minimum free energy (MFE) simultaneously. Comparative analyses reveal that sequences designed by LinearDesign2 exhibit significantly higher TIE than those designed by LinearDesign, with only a slight increase in MFE. Further, we validate the accuracy of the computational TIE metric using large-scale parallel translation experimental data. This study highlights the importance of a joint design strategy for the 5' UTR and CDS in optimizing mRNA performance, paving the way for more efficient mRNA vaccines and therapeutics.

q-bio.BM

Unifying Sequences, Structures, and Descriptions for Any-to-Any Protein Generation with the Large Multimodal Model HelixProtX

Proteins are fundamental components of biological systems and can be represented through various modalities, including sequences, structures, and textual descriptions. Despite the advances in deep learning and scientific large language models (LLMs) for protein research, current methodologies predominantly focus on limited specialized tasks -- often predicting one protein modality from another. These approaches restrict the understanding and generation of multimodal protein data. In contrast, large multimodal models have demonstrated potential capabilities in generating any-to-any content like text, images, and videos, thus enriching user interactions across various domains. Integrating these multimodal model technologies into protein research offers significant promise by potentially transforming how proteins are studied. To this end, we introduce HelixProtX, a system built upon the large multimodal model, aiming to offer a comprehensive solution to protein research by supporting any-to-any protein modality generation. Unlike existing methods, it allows for the transformation of any input protein modality into any desired protein modality. The experimental results affirm the advanced capabilities of HelixProtX, not only in generating functional descriptions from amino acid sequences but also in executing critical tasks such as designing protein sequences and structures from textual descriptions. Preliminary findings indicate that HelixProtX consistently achieves superior accuracy across a range of protein-related tasks, outperforming existing state-of-the-art models. By integrating multimodal large models into protein research, HelixProtX opens new avenues for understanding protein biology, thereby promising to accelerate scientific discovery.

cs.LG

Pre-Training on Large-Scale Generated Docking Conformations with HelixDock to Unlock the Potential of Protein-ligand Structure Prediction Models

Protein-ligand structure prediction is an essential task in drug discovery, predicting the binding interactions between small molecules (ligands) and target proteins (receptors). Recent advances have incorporated deep learning techniques to improve the accuracy of protein-ligand structure prediction. Nevertheless, the experimental validation of docking conformations remains costly, it raises concerns regarding the generalizability of these deep learning-based methods due to the limited training data. In this work, we show that by pre-training on a large-scale docking conformation generated by traditional physics-based docking tools and then fine-tuning with a limited set of experimentally validated receptor-ligand complexes, we can obtain a protein-ligand structure prediction model with outstanding performance. Specifically, this process involved the generation of 100 million docking conformations for protein-ligand pairings, an endeavor consuming roughly 1 million CPU core days. The proposed model, HelixDock, aims to acquire the physical knowledge encapsulated by the physics-based docking tools during the pre-training phase. HelixDock has been rigorously benchmarked against both physics-based and deep learning-based baselines, demonstrating its exceptional precision and robust transferability in predicting binding confirmation. In addition, our investigation reveals the scaling laws governing pre-trained protein-ligand structure prediction models, indicating a consistent enhancement in performance with increases in model parameters and the volume of pre-training data. Moreover, we applied HelixDock to several drug discovery-related tasks to validate its practical utility. HelixDock demonstrates outstanding capabilities on both cross-docking and structure-based virtual screening benchmarks.

cs.LG

HelixFold-Multimer: Elevating Protein Complex Structure Prediction to New Heights

While monomer protein structure prediction tools boast impressive accuracy, the prediction of protein complex structures remains a daunting challenge in the field. This challenge is particularly pronounced in scenarios involving complexes with protein chains from different species, such as antigen-antibody interactions, where accuracy often falls short. Limited by the accuracy of complex prediction, tasks based on precise protein-protein interaction analysis also face obstacles. In this report, we highlight the ongoing advancements of our protein complex structure prediction model, HelixFold-Multimer, underscoring its enhanced performance. HelixFold-Multimer provides precise predictions for diverse protein complex structures, especially in therapeutic protein interactions. Notably, HelixFold-Multimer achieves remarkable success in antigen-antibody and peptide-protein structure prediction, greatly surpassing AlphaFold 3. HelixFold-Multimer is now available for public use on the PaddleHelix platform, offering both a general version and an antigen-antibody version. Researchers can conveniently access and utilize this service for their development needs.

q-bio.BM

HelixFold-Single: MSA-free Protein Structure Prediction by Using Protein Language Model as an Alternative

AI-based protein structure prediction pipelines, such as AlphaFold2, have achieved near-experimental accuracy. These advanced pipelines mainly rely on Multiple Sequence Alignments (MSAs) as inputs to learn the co-evolution information from the homologous sequences. Nonetheless, searching MSAs from protein databases is time-consuming, usually taking dozens of minutes. Consequently, we attempt to explore the limits of fast protein structure prediction by using only primary sequences of proteins. HelixFold-Single is proposed to combine a large-scale protein language model with the superior geometric learning capability of AlphaFold2. Our proposed method, HelixFold-Single, first pre-trains a large-scale protein language model (PLM) with thousands of millions of primary sequences utilizing the self-supervised learning paradigm, which will be used as an alternative to MSAs for learning the co-evolution information. Then, by combining the pre-trained PLM and the essential components of AlphaFold2, we obtain an end-to-end differentiable model to predict the 3D coordinates of atoms from only the primary sequence. HelixFold-Single is validated in datasets CASP14 and CAMEO, achieving competitive accuracy with the MSA-based methods on the targets with large homologous families. Furthermore, HelixFold-Single consumes much less time than the mainstream pipelines for protein structure prediction, demonstrating its potential in tasks requiring many predictions. The code of HelixFold-Single is available at https://github.com/PaddlePaddle/PaddleHelix/tree/dev/apps/protein_folding/helixfold-single, and we also provide stable web services on https://paddlehelix.baidu.com/app/drug/protein-single/forecast.

q-bio.BM

HelixMO: Sample-Efficient Molecular Optimization in Scene-Sensitive Latent Space

Efficient exploration of the chemical space to search the candidate drugs that satisfy various constraints is a fundamental task of drug discovery. Advanced deep generative methods attempt to optimize the molecules in the compact latent space instead of the discrete original space, but the mapping between the original and latent spaces is always kept unchanged during the entire optimization process. The unchanged mapping makes those methods challenging to fast adapt to various optimization scenes and leads to the great demand for assessed molecules (samples) to provide optimization direction, which is a considerable expense for drug discovery. To this end, we design a sample-efficient molecular generative method, HelixMO, which explores the scene-sensitive latent space to promote sample efficiency. The scene-sensitive latent space focuses more on modeling the promising molecules by dynamically adjusting the space mapping by leveraging the correlations between the general and scene-specific characteristics during the optimization process. Extensive experiments demonstrate that HelixMO can achieve competitive performance with only a few assessed samples on four molecular optimization scenes. Ablation studies verify the positive impact of the scene-specific latent space, which is capable of identifying the critical characteristics of the promising molecules. We also deployed HelixMO on the website PaddleHelix (https://paddlehelix.baidu.com/app/drug/drugdesign/forecast) to provide drug design service.

cs.LG

Efficient AlphaFold2 Training using Parallel Evoformer and Branch Parallelism

The accuracy of AlphaFold2, a frontier end-to-end structure prediction system, is already close to that of the experimental determination techniques. Due to the complex model architecture and large memory consumption, it requires lots of computational resources and time to train AlphaFold2 from scratch. Efficient AlphaFold2 training could accelerate the development of life science. In this paper, we propose a Parallel Evoformer and Branch Parallelism to speed up the training of AlphaFold2. We conduct sufficient experiments on UniFold implemented in PyTorch and HelixFold implemented in PaddlePaddle, and Branch Parallelism can improve the training performance by 38.67% and 36.93%, respectively. We also demonstrate that the accuracy of Parallel Evoformer could be on par with AlphaFold2 on the CASP14 and CAMEO datasets. The source code is available on https://github.com/PaddlePaddle/PaddleFleetX

cs.DC

GEM-2: Next Generation Molecular Property Prediction Network by Modeling Full-range Many-body Interactions

Molecular property prediction is a fundamental task in the drug and material industries. Physically, the properties of a molecule are determined by its own electronic structure, which is a quantum many-body system and can be exactly described by the Schr"odinger equation. Full-range many-body interactions between electrons have been proven effective in obtaining an accurate solution of the Schr"odinger equation by classical computational chemistry methods, although modeling such interactions consumes an expensive computational cost. Meanwhile, deep learning methods have also demonstrated their competence in molecular property prediction tasks. Inspired by the classical computational chemistry methods, we design a novel method, namely GEM-2, which comprehensively considers full-range many-body interactions in molecules. Multiple tracks are utilized to model the full-range interactions between the many-bodies with different orders, and a novel axial attention mechanism is designed to approximate the full-range interaction modeling with much lower computational cost. Extensive experiments demonstrate the overwhelming superiority of GEM-2 over multiple baseline methods in quantum chemistry and drug discovery tasks. The ablation studies also verify the effectiveness of the full-range many-body interactions.

cs.LG

DuETA: Traffic Congestion Propagation Pattern Modeling via Efficient Graph Learning for ETA Prediction at Baidu Maps

Estimated time of arrival (ETA) prediction, also known as travel time estimation, is a fundamental task for a wide range of intelligent transportation applications, such as navigation, route planning, and ride-hailing services. To accurately predict the travel time of a route, it is essential to take into account both contextual and predictive factors, such as spatial-temporal interaction, driving behavior, and traffic congestion propagation inference. The ETA prediction models previously deployed at Baidu Maps have addressed the factors of spatial-temporal interaction (ConSTGAT) and driving behavior (SSML). In this work, we focus on modeling traffic congestion propagation patterns to improve ETA performance. Traffic congestion propagation pattern modeling is challenging, and it requires accounting for impact regions over time and cumulative effect of delay variations over time caused by traffic events on the road network. In this paper, we present a practical industrial-grade ETA prediction framework named DuETA. Specifically, we construct a congestion-sensitive graph based on the correlations of traffic patterns, and we develop a route-aware graph transformer to directly learn the long-distance correlations of the road segments. This design enables DuETA to capture the interactions between the road segment pairs that are spatially distant but highly correlated with traffic conditions. Extensive experiments are conducted on large-scale, real-world datasets collected from Baidu Maps. Experimental results show that ETA prediction can significantly benefit from the learned traffic congestion propagation patterns. In addition, DuETA has already been deployed in production at Baidu Maps, serving billions of requests every day. This demonstrates that DuETA is an industrial-grade and robust solution for large-scale ETA prediction services.

cs.LG

HelixFold: An Efficient Implementation of AlphaFold2 using PaddlePaddle

Accurate protein structure prediction can significantly accelerate the development of life science. The accuracy of AlphaFold2, a frontier end-to-end structure prediction system, is already close to that of the experimental determination techniques. Due to the complex model architecture and large memory consumption, it requires lots of computational resources and time to implement the training and inference of AlphaFold2 from scratch. The cost of running the original AlphaFold2 is expensive for most individuals and institutions. Therefore, reducing this cost could accelerate the development of life science. We implement AlphaFold2 using PaddlePaddle, namely HelixFold, to improve training and inference speed and reduce memory consumption. The performance is improved by operator fusion, tensor fusion, and hybrid parallelism computation, while the memory is optimized through Recompute, BFloat16, and memory read/write in-place. Compared with the original AlphaFold2 (implemented with Jax) and OpenFold (implemented with PyTorch), HelixFold needs only 7.5 days to complete the full end-to-end training and only 5.3 days when using hybrid parallelism, while both AlphaFold2 and OpenFold take about 11 days. HelixFold saves 1x training time. We verified that HelixFold's accuracy could be on par with AlphaFold2 on the CASP14 and CAMEO datasets. HelixFold's code is available on GitHub for free download: https://github.com/PaddlePaddle/PaddleHelix/tree/dev/apps/protein_folding/helixfold, and we also provide stable web services on https://paddlehelix.baidu.com/app/drug/protein/forecast.

cs.DC